Literature DB >> 30532036

New tetrahydroquinoline and indoline compounds containing a hydroxy cyclopentenone, virantmycin B and C, produced by Streptomyces sp. AM-2504.

Tōru Kimura1, Takuya Suga1, Masanori Kameoka2, Minoru Ueno2, Yuki Inahashi1,3, Hirotaka Matsuo1,3, Masato Iwatsuki1,3, Katsumi Shigemura2, Kazuro Shiomi1,3, Yōko Takahashi3, Satoshi Ōmura3, Takuji Nakashima4,5.   

Abstract

Two new antibiotics, designated virantmycin B (1) and C (2), were isolated from the cultured broth of Streptomyces sp. AM-2504. Compounds 1 and 2 were purified by Diaion HP-20, silica gel, and octadecylsilane chromatography, followed by high-performance liquid chromatography. The chemical structures of the new compounds, 1 and 2, were determined by nuclear magnetic resonance and mass spectrometry, as containing a terahydroquinoline and an indoline, respectively, each also containing a hydroxy cyclopentenone moiety. Both compounds demonstrated weak antimicrobial (both antibacterial and antifungal) activity and compound 1 also showed antiviral activity against the dengue virus, whereas compound 2 exhibited no antiviral properties.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30532036     DOI: 10.1038/s41429-018-0117-0

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  3 in total

1.  Streptomyces coeruleorubidus as a potential biocontrol agent for Newcastle disease virus.

Authors:  Rewan Abdelaziz; Yasmine H Tartor; Ahmed B Barakat; Gamal El-Didamony; Hanaa A El-Samadony; Shimaa A Amer; Marwa M Gado
Journal:  BMC Vet Res       Date:  2022-06-24       Impact factor: 2.792

Review 2.  Bacterial terpenome.

Authors:  Jeffrey D Rudolf; Tyler A Alsup; Baofu Xu; Zining Li
Journal:  Nat Prod Rep       Date:  2021-05-26       Impact factor: 15.111

3.  Antiviral activities of extremophilic actinomycetes extracts from Kazakhstan's unique ecosystems against influenza viruses and paramyxoviruses.

Authors:  Vladimir Berezin; Diyora Abdukhakimova; Lyudmila Trenozhnikova; Andrey Bogoyavlenskiy; Aizhan Turmagambetova; Alpamys Issanov; Azliyati Azizan
Journal:  Virol J       Date:  2019-12-02       Impact factor: 4.099

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.